Company

Stemline Therapeutics, Inc.

Stemline Therapeutics develops and sells oncology medicines for blood cancers and breast cancer.

About

Founded in 2003 and based in New York, Stemline Therapeutics develops oncology products, including ELZONRIS for blastic plasmacytoid dendritic cell neoplasm and ORSERDU for certain advanced breast cancers. It serves healthcare providers, hospitals, and oncology centers. The company raised USD 33 mn in an IPO in January 2013.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in